Insights From the PLCO Trial About Prostate Cancer Screening

被引：2
|
作者：
Gulati, Roman [1 ]
Albertsen, Peter C. [2 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave North,M2-B230,POB 19024, Seattle, WA 98109 USA
[2] Univ Connecticut, Ctr Hlth, Dept Surg, Div Urol, Farmington, CT USA
来源：
CANCER | 2017年 / 123卷 / 04期
关键词：
RANDOMIZED PROSTATE; MORTALITY; ERSPC;
D O I：
10.1002/cncr.30472
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：546 / 548
页数：3
相关论文
共 50 条
  • [21] Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival
    Temkin, Sarah M.
    Miller, Eric A.
    Samimi, Goli
    Berg, Christine D.
    Pinsky, Paul
    Minasian, Lori
    EUROPEAN JOURNAL OF CANCER, 2017, 87 : 182 - 188
  • [22] Modified Gleason Grade of Prostatic Adenocarcinomas Detected in the PLCO Cancer Screening Trial
    Humphrey, Peter A.
    Hickey, Thomas P.
    Riley, Thomas L.
    Mabie, Jerome E.
    Bellinger, Adam
    Strother, Marshall
    Andriole, Gerald L.
    JOURNAL OF UROLOGY, 2014, 192 (02) : 391 - 395
  • [23] Prostate Cancer Screening
    Mulhem, Elie
    Fulbright, Nikolaus
    Duncan, Norah
    AMERICAN FAMILY PHYSICIAN, 2015, 92 (08) : 683 - 688
  • [24] Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer
    Buzzoni, Carlotta
    Auvinen, Anssi
    Roobol, Monique J.
    Carlsson, Sigrid
    Moss, Sue M.
    Puliti, Donella
    de Koning, Harry J.
    Bangma, Chris H.
    Denis, Louis J.
    Kwiatkowski, Maciej
    Lujan, Marcos
    Nelen, Vera
    Paez, Alvaro
    Randazzo, Marco
    Rebillard, Xavier
    Tammela, Teuvo L. J.
    Villers, Arnauld
    Hugosson, Jonas
    Schroder, Fritz H.
    Zappa, Marco
    EUROPEAN UROLOGY, 2015, 68 (05) : 885 - 890
  • [25] Evaluating Family History Links between Breast Cancer and Prostate Cancer Among PLCO Trial Participants
    Abdel-Rahman, Omar
    CLINICAL BREAST CANCER, 2020, 20 (04) : 300 - 306
  • [26] Counseling Patients About Prostate Cancer Screening
    Stevermer, James J.
    Fink, Kenneth S.
    AMERICAN FAMILY PHYSICIAN, 2018, 98 (08) : 478 - 483
  • [27] Other and All-Cause Mortality among Men Diagnosed with Prostate Cancer in the PLCO Trial
    Stopsack, Konrad H.
    JOURNAL OF UROLOGY, 2021, 205 (05) : 1378 - 1378
  • [28] Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer
    Pasanen, Niko
    Talala, Kirsi
    Remmers, Sebastiaan
    Tammela, Teuvo L. J.
    Hugosson, Jonas
    Roobol, Monique J.
    Taari, Kimmo
    Godtman, Rebecka Arnsrud
    Bangma, Chris
    Auvinen, Anssi
    BJU INTERNATIONAL, 2024, 134 (02) : 291 - 299
  • [29] Do Men Make Informed Decisions about Prostate Cancer Screening? Baseline Results from the "Take the Wheel" Trial
    Allen, Jennifer D.
    Othus, Megan K. D.
    Hart, Alton, Jr.
    Mohllajee, Anshu P.
    Li, Yi
    Bowen, Deborah
    MEDICAL DECISION MAKING, 2011, 31 (01) : 108 - 120
  • [30] Risk of Prostate Cancer-related Death Following a Low PSA Level in the PLCO Trial
    Landy, Rebecca
    Houghton, Lauren C.
    Berg, Christine D.
    Grubb, Robert L., III
    Katki, Hormuzd A.
    Black, Amanda
    CANCER PREVENTION RESEARCH, 2020, 13 (04) : 367 - 375
12345